Agilent Technologies (A)
(Delayed Data from NYSE)
$130.85 USD
-0.55 (-0.42%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $130.87 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$130.85 USD
-0.55 (-0.42%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $130.87 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Santa Clara, CA-based Agilent Technologies, Inc. was originally a spin-off from Hewlett-Packard. The company is an original equipment manufacturer (OEM) of a broad-based portfolio of test and measurement products serving multiple end markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG). The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers’ representatives, telesales and electronic commerce.
Agilent Technologies (A) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Truth About Market Timing - July 30, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Agilent to Acquire BioTek, Cell Analysis Portfolio to Expand
by Zacks Equity Research
Agilent Technologies (A) enters into an agreement to buy BioTek Instruments, which is likely to strengthen its cell analysis capabilities and expand presence in life science research space.
5 Top & Flop ETF Areas of Q2
by Sanghamitra Saha
Dovish Fed comments and chances of U.S.-China trade truce kept the market steady in the second quarter. These ETF areas won and lost in the second quarter.
Electronics Testing Equipment Industry Outlook Appears Bright
by Shilpa Mete
Prospects of the Electronics - Testing Equipment industry look bright, thanks to the increasing proliferation of electronic devices in every major sector.
Agilent Announces Receipt of FDA Approval for pharmDX Assay
by Zacks Equity Research
Agilent (A) receives approval on the expanded use of its PD-L1 IHC 22C3 pharmDx assay.
Why Is Agilent (A) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Tense About Trade War? Follow Goldman With 5 ETF Strategies
by Sanghamitra Saha
Amid heightened US-China trade tensions, investors can land up on five ETF strategies and follow the suggestions of Goldman Sachs.
Agilent (A) Misses Earnings and Revenue Estimates in Q2
by Zacks Equity Research
Agilent (A) reports weak fiscal second-quarter results due to slowing global demand in small molecule Pharma and softness in the China Food market.
Agilent Technologies (A) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Agilent (A) delivered earnings and revenue surprises of -1.39% and -2.30%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Agilent (A) Gears Up for Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Agilent's (A) leadership position and strength in revenue segments are likely to aid fiscal second-quarter 2019 results.
Vishay Intertechnology (VSH) Q1 Earnings Top, Revenues Up Y/Y
by Zacks Equity Research
Vishay Intertechnology's (VSH) first-quarter results benefit from solid end market momentum and robust MOSFET, capacitors and, resistors and inductors.
Mettler-Toledo (MTD) Earnings & Revenues Top Estimates in Q1
by Zacks Equity Research
Mettler-Toledo (MTD) first-quarter 2019 results benefit from well-performing Laboratory and Industrial product lines.
Booking Holdings (BKNG) Q1 Earnings & Revenues Lag Estimates
by Zacks Equity Research
Currency headwinds and shift in Easter timing impact Booking Holdings' (BKNG) first-quarter 2019 results.
StoneCo (STNE) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
StoneCo's (STNE) improved features, capabilities and differentiated services that help its clients better manage businesses are likely to aid its first-quarter 2019 results.
Can New Offerings & Buyouts Aid Cisco's (CSCO) Q3 Earnings?
by Zacks Equity Research
Cisco???s (CSCO) expanding footprint in the rapidly growing security market and acquisition synergies are likely to positively impact third-quarter results.
Tencent Music (TME) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Tencent Music's (TME) first-quarter 2019 results are likely to benefit from expanding music library despite increasing content and revenue sharing fees.
Alibaba (BABA) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Alibaba's (BABA) fourth-quarter fiscal 2019 results are likely to be driven by strength in core e-commerce business. However, trade tensions and competition remain concerns.
MACOM (MTSI) Q2 Loss Wider Than Expected, Revenues Fall Y/Y
by Zacks Equity Research
MACOM's (MTSI) fiscal second-quarter results bear the impact of softness in datacenter and telecom markets.
Advanced Energy (AEIS) Q1 Earnings Beat, Revenues Down Y/Y
by Zacks Equity Research
Advanced Energy Industries' (AEIS) first-quarter results benefit from strong industrial revenues. However, softness in semiconductor market impacted the top line.
Factors Likely to Decide JD.com's (JD) Fate in Q1 Earnings
by Zacks Equity Research
Strength in e-commerce business and international expansion are likely to drive JD.com's first-quarter earnings. However, sluggishness in the third party logistics services unit remains a concern.
Itron (ITRI) Earnings and Revenues Surpass Estimates in Q1
by Zacks Equity Research
Improving customer demand and well-performing networked solutions benefit Itron's (ITRI) first-quarter results.
Agilent Technologies (A) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Agilent (A) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in Store for Booking Holdings' (BKNG) Q1 Earnings?
by Zacks Equity Research
Booking Holdings' (BKNG) Q1 earnings are likely to reflect strength in all platforms.
WESCO's (WCC) Earnings and Revenues Miss Estimates in Q1
by Zacks Equity Research
WESCO (WCC) suffers from shipment delays, branch closure and currency headwinds during first-quarter 2019.